Titan Pharmaceuticals Stock Market Value
| TTNP Stock | USD 7.32 0.22 3.10% |
| Symbol | Titan |
Titan Pharmaceuticals Price To Book Ratio
Is Titan Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Titan Pharmaceuticals. If investors know Titan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Titan Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.41) | Revenue Per Share 0.245 | Quarterly Revenue Growth (1.00) | Return On Assets (0.75) | Return On Equity (1.39) |
The market value of Titan Pharmaceuticals is measured differently than its book value, which is the value of Titan that is recorded on the company's balance sheet. Investors also form their own opinion of Titan Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Titan Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Titan Pharmaceuticals' market value can be influenced by many factors that don't directly affect Titan Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Titan Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Titan Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Titan Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Titan Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Titan Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Titan Pharmaceuticals.
| 03/20/2024 |
| 04/19/2024 |
If you would invest 0.00 in Titan Pharmaceuticals on March 20, 2024 and sell it all today you would earn a total of 0.00 from holding Titan Pharmaceuticals or generate 0.0% return on investment in Titan Pharmaceuticals over 30 days. Titan Pharmaceuticals is related to or competes with Alkermes Plc, Ironwood Pharmaceuticals, Deciphera Pharmaceuticals, Eagle Pharmaceuticals, Neurocrine Biosciences, and Dynavax Technologies. Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases More
Titan Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Titan Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Titan Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.44 | |||
| Information Ratio | 0.0411 | |||
| Maximum Drawdown | 41.59 | |||
| Value At Risk | (8.89) | |||
| Potential Upside | 9.2 |
Titan Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Titan Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Titan Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Titan Pharmaceuticals historical prices to predict the future Titan Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0412 | |||
| Jensen Alpha | 0.3574 | |||
| Total Risk Alpha | (0.28) | |||
| Sortino Ratio | 0.04 | |||
| Treynor Ratio | (0.45) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Titan Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Titan Pharmaceuticals Backtested Returns
Titan Pharmaceuticals appears to be relatively risky, given 3 months investment horizon. Titan Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0524, which indicates the firm had a 0.0524% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Titan Pharmaceuticals, which you can use to evaluate the volatility of the company. Please review Titan Pharmaceuticals' Coefficient Of Variation of 1922.46, risk adjusted performance of 0.0412, and Semi Deviation of 5.5 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Titan Pharmaceuticals holds a performance score of 4. The entity has a beta of -0.7, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Titan Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Titan Pharmaceuticals is likely to outperform the market. Please check Titan Pharmaceuticals' sortino ratio, semi variance, as well as the relationship between the Semi Variance and day median price , to make a quick decision on whether Titan Pharmaceuticals' existing price patterns will revert.
Auto-correlation | 0.17 |
Very weak predictability
Titan Pharmaceuticals has very weak predictability. Overlapping area represents the amount of predictability between Titan Pharmaceuticals time series from 20th of March 2024 to 4th of April 2024 and 4th of April 2024 to 19th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Titan Pharmaceuticals price movement. The serial correlation of 0.17 indicates that over 17.0% of current Titan Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.17 | |
| Spearman Rank Test | 0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Titan Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Titan Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Titan Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Titan Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Titan Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Titan Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Titan Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Titan Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Titan Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Titan Pharmaceuticals Lagged Returns
When evaluating Titan Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Titan Pharmaceuticals stock have on its future price. Titan Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Titan Pharmaceuticals autocorrelation shows the relationship between Titan Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Titan Pharmaceuticals.
Regressed Prices |
| Timeline |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Titan Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Titan Pharmaceuticals' short interest history, or implied volatility extrapolated from Titan Pharmaceuticals options trading.
Currently Active Assets on Macroaxis
When determining whether Titan Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Titan Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Titan Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Titan Pharmaceuticals Stock:Check out Titan Pharmaceuticals Correlation, Titan Pharmaceuticals Volatility and Titan Pharmaceuticals Alpha and Beta module to complement your research on Titan Pharmaceuticals. To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Titan Stock analysis
When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
Titan Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.